Ann: Quarterly Report and Appendix 4C, page-11

Fair call on face value comparing the two companies on paper. Also regarding our 'saviour' caption 'B' his research is second to none and his knowledge is also up there. But his approach / people skills lacks. Sorry big B not having a go directly at you just trying to explain why people are pissed even on this forum too I might add...

If this company proves good results from it's recent study out of America (take a look at the preliminary findings announced in September last year) then it's highly likely we will be generating good revenue streams.. particularly once FDA clearances granted. Yes this company is very liquid at the moment. The advantage of having a very liquid company means that with an increase in volume which I believe is forthcoming on the back of positive results will see this share price shoot up dramatically opposed to pips within your company on high volume... Anyway not having a dig two completely different companies..

All the best...

Cheers

Red bar